CHRONIC KIDNEY DISEASE (CKD) DRUG INDUSTRY MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL CHRONIC KIDNEY DISEASE (CKD) DRUG INDUSTRY MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL CHRONIC KIDNEY DISEASE (CKD) DRUG INDUSTRY MARKET

7.1 GLOBAL CHRONIC KIDNEY DISEASE (CKD) DRUG INDUSTRY MARKET SIZE AND SHARE (2018-2031) (USD MILLION)

8.1 GLOBAL CHRONIC KIDNEY DISEASE (CKD) DRUG INDUSTRY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

8.2 GLOBAL CHRONIC KIDNEY DISEASE (CKD) DRUG INDUSTRY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

9.1 GLOBAL CHRONIC KIDNEY DISEASE (CKD) DRUG INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

9.2 GLOBAL CHRONIC KIDNEY DISEASE (CKD) DRUG INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

10.1 GLOBAL CHRONIC KIDNEY DISEASE (CKD) DRUG INDUSTRY MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)

10.2 GLOBAL CHRONIC KIDNEY DISEASE (CKD) DRUG INDUSTRY MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)

11.1 NORTH AMERICA CHRONIC KIDNEY DISEASE (CKD) DRUG INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

11.2 NORTH AMERICA CHRONIC KIDNEY DISEASE (CKD) DRUG INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

11.3 NORTH AMERICA CHRONIC KIDNEY DISEASE (CKD) DRUG INDUSTRY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

11.4 NORTH AMERICA CHRONIC KIDNEY DISEASE (CKD) DRUG INDUSTRY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

11.5 NORTH AMERICA CHRONIC KIDNEY DISEASE (CKD) DRUG INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

11.6 NORTH AMERICA CHRONIC KIDNEY DISEASE (CKD) DRUG INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

12.1 EUROPE CHRONIC KIDNEY DISEASE (CKD) DRUG INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

12.2 EUROPE CHRONIC KIDNEY DISEASE (CKD) DRUG INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

12.3 EUROPE CHRONIC KIDNEY DISEASE (CKD) DRUG INDUSTRY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

12.4 EUROPE CHRONIC KIDNEY DISEASE (CKD) DRUG INDUSTRY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

12.5 EUROPE CHRONIC KIDNEY DISEASE (CKD) DRUG INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

12.6 EUROPE CHRONIC KIDNEY DISEASE (CKD) DRUG INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

13.1 ASIA PACIFIC CHRONIC KIDNEY DISEASE (CKD) DRUG INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

13.2 ASIA PACIFIC CHRONIC KIDNEY DISEASE (CKD) DRUG INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

13.3 ASIA PACIFIC CHRONIC KIDNEY DISEASE (CKD) DRUG INDUSTRY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

13.4 ASIA PACIFIC CHRONIC KIDNEY DISEASE (CKD) DRUG INDUSTRY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

13.5 ASIA PACIFIC CHRONIC KIDNEY DISEASE (CKD) DRUG INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

13.6 ASIA PACIFIC CHRONIC KIDNEY DISEASE (CKD) DRUG INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

14.1 LATIN AMERICA CHRONIC KIDNEY DISEASE (CKD) DRUG INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>

14.2 LATIN AMERICA CHRONIC KIDNEY DISEASE (CKD) DRUG INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

14.3 LATIN AMERICA CHRONIC KIDNEY DISEASE (CKD) DRUG INDUSTRY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

14.4 LATIN AMERICA CHRONIC KIDNEY DISEASE (CKD) DRUG INDUSTRY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

14.5 LATIN AMERICA CHRONIC KIDNEY DISEASE (CKD) DRUG INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

14.6 LATIN AMERICA CHRONIC KIDNEY DISEASE (CKD) DRUG INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE (CKD) DRUG INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE (CKD) DRUG INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE (CKD) DRUG INDUSTRY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE (CKD) DRUG INDUSTRY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE (CKD) DRUG INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE (CKD) DRUG INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>

16.1 FibroGen

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 Vifor Pharma Ltd

16.3 AMAG Pharmaceuticals

16.4 Keryx Biopharmaceuticals

16.5 Pharmacosmos

16.6 Johnson & Johnson

16.7 Amgen Inc

16.8 Regulus Therapeutics

16.9 Actavis PLC

16.10 Rockwell Medical

16.11 Cara Therapeutics

16.12 Reata Pharmaceuticals

16.13 Raptor Pharmaceuticals

16.14 Akebia Therapeutics

16.15 Sanofi

16.16 Takeda Pharmaceuticals

16.17 OPKO Health

16.18 ZS Pharma

16.19 F Hoffmann-La Roche Ltd

16.20 Shield Therapeutics

16.21 Abbott Laboratories

16.22 Xenetic Biosciences

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER